Waban, MA, United States of America

David P Rosenbaum



Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Waban, MA (US) (2009 - 2015)
  • Newton, MA (US) (2014 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: David P. Rosenbaum: Innovator in Gastrointestinal Treatments

Introduction

David P. Rosenbaum is a notable inventor based in Waban, MA (US), recognized for his contributions to the field of gastrointestinal treatments. He holds a total of 5 patents, focusing primarily on methods for treating various forms of irritable bowel syndrome (IBS). His innovative approaches aim to alleviate the symptoms associated with these conditions, improving the quality of life for many patients.

Latest Patents

Among his latest patents, Rosenbaum has developed a method for the treatment of diarrhea-predominant irritable bowel syndrome. This invention involves administering an inhibitor of chloride-ion transport, such as crofelemer, to patients suffering from this condition. The treatment not only addresses the diarrhea component but also alleviates pain, abdominal discomfort, and other related symptoms. Additionally, he has patented a method for treating constipation-predominant irritable bowel syndrome, which utilizes a polymeric proanthocyanidin composition, also including crofelemer. This method aims to treat both the constipation and associated discomfort experienced by patients.

Career Highlights

Rosenbaum has had a significant impact on the pharmaceutical industry through his work with companies such as Napo Pharmaceuticals, Inc. His innovative research and development efforts have led to advancements in the treatment of IBS, showcasing his dedication to improving patient care.

Collaborations

Throughout his career, Rosenbaum has collaborated with notable professionals in the field, including Barry D. Quart and Thomas Neenan. These partnerships have contributed to the successful development and implementation of his patented methods.

Conclusion

David P. Rosenbaum stands out as a key figure in the innovation of gastrointestinal treatments, with a focus on irritable bowel syndrome. His patents reflect a commitment to enhancing patient outcomes through effective therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…